Page 2 - Peterb Silverman News Today

Merus (NASDAQ:MRUS – Get Free Report) COO Peter B. Silverman sold 22,386 shares of Merus stock in a transaction on Friday, December 15th. The stock was sold at an average price of $25.00, for a total transaction of $559,650.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available […]

Merus (NASDAQ:MRUS – Get Free Report)’s share price traded up 8.4% during trading on Tuesday . The company traded as high as $27.08 and last traded at $27.05. 371,198 shares traded hands during trading, an increase of 6% from the average session volume of 349,408 shares. The stock had previously closed at $24.95. Wall Street […]

- Zenocutuzumab (Zeno) in NRG1+ cancer potential registrational path and timeline update planned for first half of 2023 - Petosemtamab clinical and regulatory update planned for first half of 2023 -

- As of year-end 2022, more than 150 patients with NRG1 gene fusion positive ("NRG1+") cancer have been treated with zenocutuzumab ("Zeno") monotherapy - Petosemtamab clinical update planned for first

- As of year-end 2022, more than 150 patients with NRG1 gene fusion positive (“NRG1+”) cancer have been treated with zenocutuzumab (“Zeno”) monotherapy -...

Merus (NASDAQ:MRUS – Get Rating) has earned an average recommendation of “Buy” from the eleven analysts that are currently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 12-month target price among brokers that […]

Equities analysts expect Merus (NASDAQ:MRUS – Get Rating) to post $10.64 million in sales for the current quarter, Zacks reports. Five analysts have issued estimates for Merus’ earnings, with the lowest sales estimate coming in at $7.90 million and the highest estimate coming in at $11.77 million. Merus posted sales of $12.38 million during the […]

Wall Street brokerages expect Merus (NASDAQ:MRUS – Get Rating) to announce sales of $8.55 million for the current quarter, Zacks reports. Five analysts have issued estimates for Merus’ earnings. The highest sales estimate is $11.53 million and the lowest is $3.33 million. Merus posted sales of $8.35 million in the same quarter last year, which […]

Wall Street analysts expect Merus (NASDAQ:MRUS – Get Rating) to report ($0.66) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Five analysts have issued estimates for Merus’ earnings, with the lowest EPS estimate coming in at ($0.73) and the highest estimate coming in at ($0.56). Merus reported earnings of ($0.28) per […]

Brokerages expect Merus (NASDAQ:MRUS – Get Rating) to post $8.55 million in sales for the current fiscal quarter, Zacks Investment Research reports. Five analysts have provided estimates for Merus’ earnings. The highest sales estimate is $11.53 million and the lowest is $3.33 million. Merus reported sales of $8.35 million during the same quarter last year, […]